Filing Details

Accession Number:
0001140361-15-013272
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-26 18:53:43
Reporting Period:
2015-03-25
Filing Date:
2015-03-26
Accepted Time:
2015-03-26 18:53:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
913077 Affymetrix Inc AFFX Laboratory Analytical Instruments (3826) 770319159
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1485088 J. Andrew Last C/O Affymetrix, Inc.
3420 Central Expressway
Santa Clara CA 95051
Evp, Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-25 90,000 $5.29 260,112 No 4 M Direct
Common Stock Acquisiton 2015-03-25 20,000 $4.22 280,112 No 4 M Direct
Common Stock Disposition 2015-03-25 110,000 $12.79 170,112 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock Disposition 2015-03-25 90,000 $0.00 90,000 $5.29
Common Stock Option to Purchase Common Stock Disposition 2015-03-25 20,000 $0.00 20,000 $4.22
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-12-17 No 4 M Direct
50,000 2017-08-19 No 4 M Direct
Footnotes
  1. Sold pursuant to a 10b5-1 Trading Plan.
  2. These sales were executed in multiple trades at prices ranging from $12.685 to $12.99. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  3. Stock option became exercisable in equal annual installments over four years from the grant date of December 17, 2009.
  4. Stock option became exercisable in equal annual installments over four years from the grant date of August 19, 2010.